Marinus Pharmaceuticals (MRNS) Priced

Early-stage biotech developing an add-on therapy for epilepsy.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $1.35 -0.10 (-6.9%)
First Day Return 0.0%
Return from IPO -81.9%
 
Marinus Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 05/12/2014
Offer Price $8.00
Price Range $12.00 - $14.00
Offer Shares (mm) 5.6
Deal Size ($mm) 45
 
IPO Data
IPO Date 07/31/2014
Offer Price $8.00
Price Range $12.00 - $14.00
Offer Shares (mm) 5.6
Deal Size ($mm) $45
 
Underwriters
more
Business Overview
Early-stage biotech developing an add-on therapy for epilepsy.
Early-stage biotech developing an add-on therapy for epilepsy.
more
Company Data
Headquarters New Haven, CT
Founded 2003
Employees 4
Website www.marinuspharma.com
 

Performance vs. IPO Index (IPOUSA)